Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia | MicrobiomeTrials← Back to trialsNCT07393373
Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia
ENROLLING_BY_INVITATIONPHASE2INTERVENTIONAL
Trial Details
Start: 2026-04-23Est. Completion: 2036-05-31
Enrollment target: 135 participants Locations- UCSF Benioff Children's Hospital, Oakland, California, United States
- Childrens Hospital Colorado, Aurora, Colorado, United States
- Children's National Hospital, Washington D.C., District of Columbia, United States
- Johns Hopkins School of Medicine, Baltimore, Maryland, United States
- University of Missouri, Columbia, Missouri, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- University of Wisconsin Madison - Waisman Center Bone Dysplasia Clinic, Madison, Wisconsin, United States
- Murdoch Children's Research Institute - The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia
- London Health Sciences Centre - Children's Hospital of Western Ontario, London, Ontario, Canada
- Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada
- Université de Montréal - Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada
- Hôpital Femme Mère Enfant, Bron, France
- Hôpital Universitaire Necker-Enfants Malades, Paris, France
Other microbiome trials you might be interested in
Hypochondroplasia
The purpose of this study is to evaluate the long-term safety and efficacy of daily doses of vosoritide in participants …
Phoenix, United StatesCompleted Oct 2044
Hypochondroplasia
ACCEL2/3 is a Phase 2/3 study. The purpose of the Phase 2 portion of the study (ACCEL2/3) is to evaluate the efficacy an…
Oakland, United StatesCompleted Jan 2027
Centre Hospitalier Universitaire (CHU) de Toulouse - Hôpital des Enfants, Toulouse, FranceHaukeland University Hospital, Bergen, NorwayPaediatric Clinical Research Unit at Oslo University Hospital, Oslo, NorwayHospital Pediátrico de Coimbra, Coimbra, PortugalKK Women's and Children's Hospital, Singapore, SingaporeUnidad de Cirugía Artroscopica, Hopsital MIKS, Vitoria-Gasteiz, SpainAstrid Lindgren Children's Hospital, Solna, SwedenManchester University, Manchester, England, United KingdomSheffield Children's Hospital, Sheffield, England, United KingdomGlasgow Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, Scotland, United Kingdom